Anyone heard of this??

Options
smokeyjoe
smokeyjoe Member Posts: 1,425 Member
in Colorectal Cancer #1
•The drug R935788 (fostamatanib disodium) is a kinase inhibitor (i.e., it interferes with cell communication and growth and may prevent tumor growth).
•R935788 has shown promising activity in NCI-60 (a panel of 60 diverse human cancer cell lines) against colon cancer, non-small cell lung cancer, and renal cell carcinoma cell lines, as well as in two renal cell xenograft models.
•This is an open-label, Phase II study of R935788. Phase I studies in patients with immune thrombocytopenic purpura, rheumatoid arthritis, and lymphoma have demonstrated safety with a continuous dosing schedule, and a maximum tolerated dose has been established

Comments

  • pepebcn
    pepebcn Member Posts: 6,331 Member
    #2
    Options
    Was taking a look seems promising but not to be present to FDA
    until 2013!.
    Hugs!
  • John23
    John23 Member Posts: 2,122 Member
    #3
    Options
    data in / data out
    Re:
    •The drug R935788 (fostamatanib disodium) is a kinase inhibitor
    (i.e., it interferes with cell communication and growth and may prevent
    tumor growth).

    "may".... hmm...

    This is a drug designed to "interfere with cell communication".

    Good cells can communicate; cancer cells have lost their
    ability to communicate, that's why they grow uncontrolled.

    Oh well....

    Best wishes,

    John

Discussion Boards